- Like it or not, capital gain prospects for stocks in U.S. equities markets are all directly comparable with one another, and investors who want those gains need to make comparisons.
- The comparability comes from big-money transaction pressures by competing “Institutional” investment organizations adjusting multi-Billion-$ portfolio holdings.
- Transactions negotiated among Institutions by Market-Makers usually require the MMs risking firm capital – risks not taken without hedging costs accepted by the trade order originator.
- That hedging in leveraged “derivative” securities defines how far (both upside and downside) the subject stock’s price is likely to go – worth paying a price to protect against.
- How equities markets have reacted to those Risk~Reward tradeoffs provides an opportunity shopping list.
For further details see:
Zai Lab: Best Now Capital Gain Biotech For Near-Term Wealth-Building, So Say Market-Makers